Black Bird Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 04:26 pm EST
Share
Black Bird Biotech, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.025739 million compared to USD 0.046694 million a year ago. Net loss was USD 0.224793 million compared to USD 0.451677 million a year ago.
For the nine months, sales was USD 0.070484 million compared to USD 0.081906 million a year ago. Net loss was USD 1.42 million compared to USD 0.925724 million a year ago.
Black Bird Biotech, Inc. is a manufacturer and distributor for MiteXstream, an environmental protection agency (EPA)-certified plant-based biopesticide effective in the eradication of mites and other similar pests, including spider mites, that destroy crops, particularly cannabis, hops, coffee and house plants, as well as molds and mildew. The Company also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The Company's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.
BLACK BIRD BIOTECH, INC. 
